EUVIMEDOpdag EUVIMED
FallberichtOpen access

Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report

Hidetaka Kuroda, Tomomi Katayama, Atsuki Yamaguchi, Norika Katagiri, Shota Tsukimoto, Uno Imaizumi, Takuro Sanuki

Anesthesia Progress · 2024

DOI: 10.2344/021627 ↗

At a glance

Fallbericht in Anesthesia Progress, 2024. Written by Hidetaka Kuroda and 6 co-authors. Major MEDLINE topics: Rocuronium, Sugammadex, Neuromuscular Nondepolarizing Agents, Polymyositis. 17 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Muscle relaxants and their reverse drugs should be carefully administered to patients with acute polymyositis and/or dermatomyositis. However, the use of these drugs in controlled polymyositis and/or dermatomyositis is controversial. This case report describes the use of rocuronium and sugammadex in a 27-year-old female patient with controlled polymyositis who was scheduled for minor oral surgery under general anesthesia. General anesthesia was induced rapidly, and 0.66 mg/kg of rocuronium was administered prior to nasotracheal intubation. No additional muscle relaxants were administered during the surgery. At the end of surgery, approximately 2 hours after the rocuronium was administered, her train-of-four (TOF) ratio was still 49%. A dose of 3.3 mg/kg of sugammadex was administered, and it took 12 minutes for the TOF ratio to exceed 90%. The prolonged duration of muscle relaxation in patients with polymyositis may be due to a decrease in skeletal muscle and capillary volume. The slow onset of sugammadex may be caused by slow diffusion of rocuronium from the neuromuscular junction. Patients with polymyositis require close perioperative neuromuscular function monitoring, regardless of their disease control status.

Subjects

MeSH terms (MEDLINE)

RocuroniumSugammadexNeuromuscular Nondepolarizing AgentsPolymyositisAnesthesia, Generalgamma-CyclodextrinsHumansFemaleAdultAndrostanolsOral Surgical ProceduresNeuromuscular BlockadeNeuromuscular Monitoring

Author keywords

General anesthesiaPolymyositisRocuroniumSugammadex

Substances

RocuroniumSugammadexNeuromuscular Nondepolarizing Agentsgamma-CyclodextrinsAndrostanols

Cite

APA

Kuroda, H., Katayama, T., Yamaguchi, A., Katagiri, N., Tsukimoto, S., Imaizumi, U., & Sanuki, T. (2024). Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report. Anesthesia Progress. https://doi.org/10.2344/021627

Vancouver

Kuroda H, Katayama T, Yamaguchi A, Katagiri N, Tsukimoto S, Imaizumi U, et al. Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report. Anesthesia Progress. 2024. doi:10.2344/021627

BibTeX
@article{Kuroda2024,
  author = {Kuroda, Hidetaka and Katayama, Tomomi and Yamaguchi, Atsuki and Katagiri, Norika and Tsukimoto, Shota and Imaizumi, Uno and Sanuki, Takuro},
  title = {Use of Rocuronium and Sugammadex for a Patient With Controlled Polymyositis: A Case Report},
  journal = {Anesthesia Progress},
  year = {2024},
  doi = {10.2344/021627}
}
Start for free →